Abstract
The study focused on chronic kidney disease (CKD), emphasizing the need for early screening and treatment to prevent its progression. Conducted on 65 CKD patients, this prospective observational research aimed to analyze prescription patterns and identify drug-related issues (DRIs). Using the Pharmaceutical Care Network Europe categorization V 5.01, the study evaluated prescriptions and categorized DRPs. The participant group comprised 65 individuals, predominantly male (69.03%), with an average age of 44. The two primary comorbidities were diabetes mellitus (29.78%) and hypertension (34.97%). Notably, the average prescription count was 10, suggesting polypharmacy. Antibiotics emerged as the most commonly prescribed medication (13.98%). The study found medication interactions to be the most frequent DRP (48.54%), followed by drug choice problems (18.43%), dosage issues (8.36%), drug usage complications (10.46%), adverse reactions (1.24%), and other issues (11.28%). Lack of knowledge (42.16%) and the drug use process (30.81%) were identified as the leading causes of DRPs. The research underscores the critical role of continuous identification and management of DRPs by healthcare professionals to enhance patient health and quality of life, potentially leading to better clinical outcomes for CKD patients.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call